Stelac Advisory Services’s Novo Nordisk NVO Stock Holding History

Stelac Advisory Services’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.88M	Hold	60,105	–	–	0.54%	45
2026 Q1	$2.26M	Buy	+60,105	New	+$2.85M	0.46%	60
2023 Q2	–	Sell	-11,788	Closed	-$938K	–	161
2023 Q1	$938K	Buy	+11,788	New	+$836K	0.41%	41
2022 Q4	–	Sell	-11,254	Closed	-$561K	–	164
2022 Q3	$561K	Hold	11,254	–	–	0.26%	61
2022 Q2	$627K	Buy	+11,254	New	+$624K	0.25%	56

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Stelac Advisory Services's NVO Position: Q2 2026 in Review

Stelac Advisory Services held its Novo Nordisk (NVO) position steady in Q2 2026 at 60,105 shares worth $2.88M. The position accounts for 0.54% of the portfolio, ranked #45.

Stelac Advisory Services first reported a position in NVO in Q2 2022 and has held it in 5 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Stelac Advisory Services held 60,105 shares of Novo Nordisk worth $2.88M as of Q2 2026.
Stelac Advisory Services left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.54% of Stelac Advisory Services's portfolio in Q2 2026, its #45 holding.
Stelac Advisory Services first reported a position in Novo Nordisk in Q2 2022 and has held it in 5 quarters since.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Stelac Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.